A Born Leader: A conversation with Ginger Graham, Part 1
Release Date: 06/02/2021
Leading With His Heart - A Conversation with Allan Will (Part 2)
MedTech Trailblazers
Allan Will is one of the founding architects of the medtech industry. Raised by parents who were outspoken supporters of equality and human rights, his desire to help people, passion for science, and business acumen came together in an early job helping Abbott Labs expand into interventional medicine. Just five years later, he was leading DVI, one of the first atherectomy companies, from a 16-person team to a 600-person powerhouse. With a leadership style marked by a patient-centric focus, high expectations, relentless questioning, and an emphasis on authenticity, he helped bring forth...
info_outline
Leading With His Heart - A Conversation with Allan Will (Part 1)
MedTech Trailblazers
Allan Will is one of the founding architects of the medtech industry. Raised by parents who were outspoken supporters of equality and human rights, his desire to help people, passion for science, and business acumen came together in an early job helping Abbott Labs expand into interventional medicine. Just five years later, he was leading DVI, one of the first atherectomy companies, from a 16-person team to a 600-person powerhouse. With a leadership style marked by a patient-centric focus, high expectations, relentless questioning, and an emphasis on authenticity, he helped bring forth...
info_outline
Sam Conaway: Turning Obstacles into Opportunities - Part 2
MedTech Trailblazers
Sam Conaway is the president of U.S. Cardiology Sales for and the chair of the company’s Close the Gap program, which seeks to eliminate treatment disparities in underserved populations. He has been recognized as one of the most influential Black executives in corporate America (SAVOY Magazine), and in healthcare (BlackDoctor.org), and was the first recipient of the ’s "Pulse-Setter Leader Award" for his commitment to advancing health equity. Sam’s road to these achievements, however, was littered with obstacles that could easily have been roadblocks. Sam grew up poor, in a rough...
info_outline
Sam Conaway: Turning Obstacles into Opportunities - Part 1
MedTech Trailblazers
Sam Conaway is the president of U.S. Cardiology Sales for and the chair of the company’s Close the Gap program, which seeks to eliminate treatment disparities in underserved populations. He has been recognized as one of the most influential Black executives in corporate America (SAVOY Magazine), and in healthcare (BlackDoctor.org), and was the first recipient of the ’s "Pulse-Setter Leader Award" for his commitment to advancing health equity. Sam’s road to these achievements, however, was littered with obstacles that could easily have been roadblocks. Sam grew up poor, in a rough...
info_outline
Kendal Whitlock's Mission to Solve Inequities in Clinical Trials - Part 2
MedTech Trailblazers
Kendal Whitlock is a problem solver. In her current position as the Head of Digital Optimization, RWE Clinical Trials for Walgreens Boots Alliance, she is working to make it possible for all patients to participate in medical research, regardless of where they live, through decentralized clinical trials and enabling digital technologies. In this second episode of a two-part interview with Andrew Cleeland, CEO of Fogarty Innovation, Kendal describes her career path, explains Walgreens' "game changing" approach to clinical trial recruitment, and reflects on learning from failure and being true...
info_outline
Kendal Whitlock's Mission to Solve Inequities in Clinical Trials
MedTech Trailblazers
Kendal Whitlock is a problem solver. In her current position as the Head of Digital Optimization, RWE Clinical Trials for Walgreens Boots Alliance, she is working to make it possible for all patients to participate in medical research, regardless of where they live, through decentralized clinical trials and enabling digital technologies. Kendal’s journey has always been about leveraging her passion for scientific evidence with her desire to be a bridge between that information and the communities and people who need it. Shaping her path has been a series of influential mentors – from her...
info_outline
1,800 Patents and Counting: Serial innovator Mir Imran on curiosity, determination, and which problems are worth solving (part 2)
MedTech Trailblazers
In this second of two parts, serial innovator and entrepreneur Mir Imran rejoins Andrew Cleeland, CEO of Fogarty Innovation, to discuss his reluctant path through medical school, the inspiration that led him to develop the first automatic implantable cardiac defibrillator, how he views innovation and chooses problems to solve, and the stories behind the founding of Ventritex and Rani Therapeutics. Mir has spent 40 years developing and commercializing breakthrough medical technologies that have saved millions of lives. He has founded more than 20 life science companies including Ventritex,...
info_outline
1,800 Patents and Counting: Serial innovator Mir Imran on curiosity, determination, and which problems are worth solving (part 1)
MedTech Trailblazers
Mir Imran has an insatiable interest in unsolved clinical problems and a relentless entrepreneurial drive. The result has been a 40-year career developing and commercializing breakthrough medical technologies that have saved millions of lives. Mir has helped shape the medical device industry, founding more than 20 life science companies including Ventritex, Cardiac Pathways, Percusurge and most recently, Rani Therapeutics. Most of these startups have been acquired by larger companies or gone public. In this episode, Mir joins Andrew Cleeland, CEO of Fogarty Innovation, to share the insights...
info_outline
John Simpson Builds His Successful Career on Constantly Striving for a Better Way (Part 2)
MedTech Trailblazers
World-renowned physician, venture capitalist and prolific entrepreneur, John Simpson, MD, rejoins Andrew Cleeland to discuss the impact he's had on the future generation of medtech innovators. Credited with inventing and commercializing the first over-the-wire balloon catheter used for percutaneous transluminal coronary angioplasty (PTCA) and helping to create the field of interventional cardiology, John also founded and successfully exited numerous companies, including Advanced Cardiovascular Systems (ACS) and Devices for Vascular Intervention (DVI), which were both acquired by Eli Lily;...
info_outline
John Simpson Builds His Successful Career on Constantly Striving for a Better Way (Part 1)
MedTech Trailblazers
A husband, father, world-renowned physician, venture capitalist and prolific entrepreneur, , MD, has helped revolutionize the field of cardiology via his innovations. Credited with inventing and commercializing the first over-the-wire balloon catheter used for percutaneous transluminal coronary angioplasty (PTCA) and helping to create the field of interventional cardiology, John also founded and successfully exited numerous companies, including Advanced Cardiovascular Systems (ACS) and Devices for Vascular Intervention (DVI), which were both acquired by Eli Lily; CVIS, acquired by...
info_outlineThe field of MedTech uses the latest technology to address medical challenges and find new ways to transform patient care. The industry is filled with groundbreaking experts paving the way to a better and healthier future— transforming patient care and saving countless lives. In this exciting new podcast, Andrew Cleeland invites listeners to tune in as he interviews MedTech professionals about their journeys to success and how their innovative contributions are disrupting and transforming the industry.
Andrew Cleeland welcomes Ginger Graham as the guest in this pilot episode. Ginger Graham is the owner of Ginger & Baker, and Chairman at Clovis Oncology, Inc. She is the former President and CEO of Amylin Pharmaceuticals and also serves on the boards of directors for Walgreen Co., Walgreens Boots Alliance, and several other biotech companies. She joins Andrew Cleeland to share her story - her successes, her failures, her mistakes, and the challenges she overcame. Additionally, she shares lessons she learned along the way and impactful advice that she applied to her personal and professional life.
One such lesson is about maximizing your full potential. We all have a gift in life that is uniquely ours, and the onus is on us to use it to our full ability. We have a responsibility to ourselves and everyone who has supported us to be our best selves.
Resources
Biography:
Ginger began her healthcare career at Eli Lilly, the starting point for many pivotal leaders in our industry. Her career highlights include roles as CEO of Advanced Cardiovascular Systems (ACS); group chairman for the Office of the President at Guidant Corporation as the company launched the world’s leading stent platform; and president and CEO of Amylin Pharmaceuticals, a biotech company that she took public.
She currently serves on numerous boards, including Walgreens Boots Alliance, Genomic Health and Elcelyx Therapeutics; and she co-chairs the Scientific Council of the University of Colorado Center for Women's Health Research. She has come full circle as a faculty member at Harvard Business School; an accomplished writer, she has written for the Harvard Business Review and serves on the University of Arkansas Chancellor's Board of Advisors. Ginger is the recipient of numerous awards, including being listed in Pharma VOICE’s “100 of the Most Inspiring People,” among many others. True to her philanthropic spirit, in her spare time she coaches first-time CEOs in leadership strategy and organization building.
SHOW LESS